Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Grant/Award of 25,000 GANX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 25,000 | n/a |
| Jun 10, 2026 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/Award | 25,000 | $217.5K |
| Jun 25, 2025 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |
| Jun 4, 2025 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/Award | 25,000 | $197.0K |
| Aug 19, 2024 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/Award | 25,000 | $139.5K |
| Aug 12, 2024 | Gain Therapeutics, Inc. (GANX) | Purchase | 50,000 | $49.9K |
| Jun 27, 2024 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |
| Nov 16, 2023 | FENNEC PHARMACEUTICALS INC. (FENC) | Exercise/Conversion | 133,333 | $308.0K |
| Jun 26, 2023 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 10,500 | n/a |
| Jun 13, 2023 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/Award | 25,000 | n/a |